Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Snail $15 million IPO
We advised Snail on its IPO and Nasdaq listing
Molded Devices acquisition of GlobalMed and Schauenburg-Truplast
We advised Molded Devices on the acquisition and the related financing arrangements
TIAA sale of TIAA Bank
We are advising TIAA on the transaction
Emerson $14 billion sale of Climate Technologies to Blackstone
We are advising Emerson on the transaction
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
PGT Innovations $185 million acquisition of Martin Door
We advised PGT Innovations on the transaction
Arco Platform acquisition of isaac
We are advising Arco Platform on the acquisition
Billtrust $1.7 billion acquisition by EQT Private Equity
We are advising Billtrust on the transaction
LiveWire $1.77 billion merger with AEA-Bridges Impact
We advised several financial institutions on the de-SPAC transaction of the Harley-Davidson division